Metabolic risk Clinical Trials

1 recruiting

Metabolic risk Trials at a Glance

14 actively recruiting trials for metabolic risk are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Singapore, Birmingham, and Boston. Lead sponsors running metabolic risk studies include Anhui Medical University, Asian Institute Of Medical Sciences, and Ana Mª Garcia Munoz.

Browse metabolic risk trials by phase

Treatments under study

About Metabolic risk Clinical Trials

Looking for clinical trials for Metabolic risk? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Metabolic risk trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Metabolic risk clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Not Applicable

Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health

Sedentary BehaviorCardiometabolic Risk FactorsBlood Pressure+1 more
Columbia University324 enrolled1 locationNCT05353322
Recruiting
Phase 4

Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults

ObesityCardiometabolic Risk FactorsWeight Reduction
Asian Institute Of Medical Sciences60 enrolled1 locationNCT07513168
Recruiting
Not Applicable

Effect of Ginger Capsules on Inflammation, Oxidative Stress, and Endothelial Function

Cardiometabolic Risk FactorsOxidative StressInflammation Biomarkers
Ana Mª Garcia Munoz50 enrolled1 locationNCT07437222
Recruiting
Not Applicable

Effect of a Ginger-Based Beverage on Inflammation, Oxidative Stress, and Endothelial Function

Cardiometabolic Risk FactorsOxidative StressInflammation Biomarkers
Javier Marhuenda50 enrolled1 locationNCT07433998
Recruiting
Phase 4

DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis

Cardiometabolic Risk FactorsCirrhosisCirrhotic Cardiomyopathy+1 more
Post Graduate Institute of Medical Education and Research, Chandigarh400 enrolled1 locationNCT07322237
Recruiting
Not Applicable

Alternative Physical Activity Strategies for Breast Cancer Survivors

Breast CancerInsulin ResistanceCardiometabolic Risk Factors
University of Toronto24 enrolled1 locationNCT06633380
Recruiting
Not Applicable

Effect of Vitamin D on Cardiovascular Metabolic Risk in Overweight/Obesity Adolescents in China

Cardiometabolic Risk Factors
Anhui Medical University130 enrolled2 locationsNCT07053657
Recruiting
Not Applicable

Delta GREENS Food is Medicine Intervention

ObesityCardiometabolic Risk FactorsDiabetes+2 more
Tufts University300 enrolled1 locationNCT06358859
Recruiting

Associations Between Dietary Intake and Cardiometabolic and Gut Microbiota Outcomes

Cardiometabolic Risk Factors
National University of Singapore240 enrolled1 locationNCT06775132
Recruiting
Not Applicable

Cardiometabolic Health Intervention Using Movement-to-Music Exercise

Cardiometabolic Risk Factors in Adult Wheelchair Users
University of Alabama at Birmingham132 enrolled1 locationNCT05606432
Recruiting
Not Applicable

Asian-Mediterranean Diet and Women's Health

Cardiometabolic Risk Factors
Global Centre for Asian Women's Health300 enrolled1 locationNCT06825936
Recruiting
Not Applicable

Impact of Ultra-processed Foods on Cardiometabolic Risk Factors

Cardiometabolic Risk
Laval University120 enrolled1 locationNCT06538831
Recruiting
Phase 4

Study investigating whether the drug semaglutide could be a safe and effective way of reducing metabolic problems, such as a high Body Mass Index (BMI) and high blood sugar levels, in people with psychosis.

Metabolic riskPsychosis
South Eastern Sydney Local Health District100 enrolled1 locationACTRN12621001434886
Recruiting

Fibre supplementation to decrease hunger, improve chronic disease risk factors and weight loss in overweight and obese children.

Metabolic risk factors
Curtin University70 enrolled1 locationACTRN12617000960358